Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Am J Vet Res ; 68(10): 1041-4, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17916007

RESUMEN

OBJECTIVE: To determine the pharmacokinetics of gallium maltolate (GaM) after intragastric administration in healthy foals. ANIMALS: 6 healthy neonatal foals. PROCEDURES: Each foal received GaM (20 mg/kg) by intragastric administration. Blood samples were obtained before (time 0) and at 0.25, 0.5, 1, 2, 4, 8, 12, 24, 36, and 48 hours after GaM administration for determination of serum gallium concentrations by use of inductively coupled plasma mass spectroscopy. RESULTS: Mean +/- SD pharmacokinetic variables were as follows: peak serum gallium concentration, 1,079 +/- 311 ng/mL; time to peak serum concentration, 4.3 +/- 2.0 hours; area under the serum concentration versus time curve, 40,215 +/- 8,420 ng/mL/h; mean residence time, 39.5 +/- 17.2 hours; area under the moment curve, 1,636,554 +/- 931,458 ng([h](2)/mL); and terminal half-life, 26.6 +/- 11.6 hours. The mean serum concentration of gallium at 12 hours was 756 +/- 195 ng/mL. CONCLUSIONS AND CLINICAL RELEVANCE: Gallium maltolate administered via nasogastric tube at a dose of 20 mg/kg to neonatal foals resulted in gallium serum concentrations considered sufficient to suppress growth or kill Rhodococcus equi in macrophages and other infected tissues.


Asunto(s)
Galio/sangre , Caballos/metabolismo , Compuestos Organometálicos/farmacocinética , Pironas/farmacocinética , Administración Oral , Animales , Animales Recién Nacidos , Área Bajo la Curva , Galio/administración & dosificación , Galio/farmacocinética , Cinética , Compuestos Organometálicos/administración & dosificación , Compuestos Organometálicos/sangre , Pironas/administración & dosificación , Pironas/sangre
2.
Am J Vet Res ; 68(1): 63-71, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17199420

RESUMEN

OBJECTIVE: To determine whether mares are a clinically important source of Rhodococcus equi for their foals. SAMPLE POPULATION: 171 mares and 171 foals from a farm in Kentucky (evaluated during 2004 and 2005). PROCEDURES: At 4 time points (2 before and 2 after parturition), the total concentration of R equi and concentration of virulent R equi were determined in fecal specimens from mares by use of quantitative bacteriologic culture and a colony immunoblot technique, respectively. These concentrations for mares of foals that developed R equi-associated pneumonia and for mares with unaffected foals were compared. Data for each year were analyzed separately. RESULTS: R equi-associated pneumonia developed in 53 of 171 (31%) foals. Fecal shedding of virulent R equi was detected in at least 1 time point for every mare; bacteriologic culture results were positive for 62 of 171 (36%) mares at all time points. However, compared with dams of unaffected foals, fecal concentrations of total or virulent R equi in dams of foals with R equi-associated pneumonia were not significantly different. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicate that dams of foals with R equi-associated pneumonia did not shed more R equi in feces than dams of unaffected foals; therefore, R equi infection in foals was not associated with comparatively greater fecal shedding by their dams. However, detection of virulent R equi in the feces of all mares during at least 1 time point suggests that mares can be an important source of R equi for the surrounding environment.


Asunto(s)
Infecciones por Actinomycetales/veterinaria , Enfermedades de los Caballos/microbiología , Neumonía Bacteriana/veterinaria , Rhodococcus equi/crecimiento & desarrollo , Infecciones por Actinomycetales/microbiología , Infecciones por Actinomycetales/transmisión , Animales , Animales Recién Nacidos , Recuento de Colonia Microbiana/veterinaria , Heces/microbiología , Femenino , Enfermedades de los Caballos/transmisión , Caballos , Immunoblotting/veterinaria , Transmisión Vertical de Enfermedad Infecciosa , Neumonía Bacteriana/microbiología , Embarazo , Rhodococcus equi/patogenicidad , Estadísticas no Paramétricas , Virulencia
3.
Am J Vet Res ; 66(5): 755-61, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15940818

RESUMEN

OBJECTIVE: To evaluate a real-time quantitative polymerase chain reaction (QPCR) assay in the detection and quantitation of virulent Rhodococcus equi. SAMPLE POPULATION: 1 virulent, 2 intermediately virulent, and 2 avirulent strains of R. equi and 16 isolates of bacteria genetically related to R. equi. PROCEDURE: The QPCR assay was evaluated for detection and quantitation of the virulence-associated gene (vapA) of R. equi in pure culture and in samples of tracheobronchial fluid, which were inoculated with known numbers of virulent R. equi. Results were compared with those derived via quantitative microbial culture and standard polymerase chain reaction methods. RESULTS: The QPCR assay detected the vapA gene in pure culture of R. equi and in tracheobronchial fluid samples that contained as few as 20 CFUs of virulent R. equi/mL and accurately quantitated virulent R. equi to 10(3) CFUs/mL of fluid. The assay was highly specific for detection of the vapA gene of virulent R. equi and was more sensitive than standard polymerase chain reaction for detection of R. equi in tracheobronchial fluid. CONCLUSIONS AND CLINICAL RELEVANCE: The QPCR assay appears to be a rapid and reliable method for detecting and quantitating virulent R. equi. The accuracy of the QPCR assay is comparable to that of quantitative microbial culture. The increased sensitivity of the QPCR method in detection of virulent R. equi should facilitate rapid and accurate diagnosis of R. equi pneumonia in foals.


Asunto(s)
Infecciones por Actinomycetales/veterinaria , Enfermedades de los Caballos/microbiología , Reacción en Cadena de la Polimerasa/métodos , Rhodococcus equi/aislamiento & purificación , Rhodococcus equi/patogenicidad , Infecciones por Actinomycetales/diagnóstico , Animales , Líquido del Lavado Bronquioalveolar/microbiología , ADN Bacteriano/análisis , Enfermedades de los Caballos/diagnóstico , Caballos , Sensibilidad y Especificidad , Virulencia
4.
Am J Vet Res ; 64(11): 1337-46, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14620767

RESUMEN

OBJECTIVE: To determine the importance of iron for in vitro growth of Rhodococcus equi, define potential iron sources in the environment and mechanisms by which R equi may obtain iron from the environment, and assess expression and immunogenicity of iron-regulated proteins. SAMPLE POPULATION: 10 virulent and 11 avirulent strains of R equi. PROCEDURE: In vitro growth rates and protein patterns of R equi propagated in media with normal, excess, or limited amounts of available iron were compared. Immunoblot analyses that used serum from foals naturally infected with R equi and monoclonal antibody against virulence-associated protein (Vap)A were conducted to determine immunogenicity and identity of expressed proteins. RESULTS: Excess iron did not alter growth of any R equi strains, whereas growth of all strains was significantly decreased in response to limited amounts of available iron. Virulent R equi were able to use iron from ferrated deferoxamine, bovine transferrin, and bovine lactoferrin. Only virulent R equi expressed an iron-regulated, immunogenic, surface-associated protein identified as VapA. CONCLUSIONS AND CLINICAL RELEVANCE: Iron is required for the growth and survival of R equi. Sources of iron for R equi, and mechanisms by which R equi acquire iron in vivo, may represent important virulence factors and novel targets for the development of therapeutic and immunoprophylactic strategies to control R equi infection in foals. Expression of VapA is substantially upregulated when there is a limited amount of available iron.


Asunto(s)
Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Hierro/farmacología , Lipoproteínas/genética , Rhodococcus equi/crecimiento & desarrollo , Factores de Virulencia/genética , Medios de Cultivo , Deferoxamina/farmacología , Rhodococcus equi/efectos de los fármacos , Rhodococcus equi/genética , Virulencia
5.
Vet Immunol Immunopathol ; 150(1-2): 10-8, 2012 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-22901428

RESUMEN

The innate immune system plays a critical role in protecting neonates against infections early in life and Toll-like receptors (TLRs) are key components of innate immune recognition of pathogens. This study examined the effects of age and stimulation with a TLR 7/8 agonist (R848) on TLR8 mRNA expression by foal neutrophils during the first month of life. We also examined the effects of R848 stimulation on mRNA expression of interleukin (IL)-6 and IL-8 at 1 and 14 days of life. We observed that TLR8 mRNA was constitutively expressed (P<0.05) at all ages examined, and its expression did not change upon stimulation with R848. Stimulation with R848 resulted in significantly increased (P<0.05) expression of IL-6 and IL-8 mRNA at both 1 and 14 days of life. Our results demonstrate that foal neutrophils express constitutive levels of TLR8 mRNA. The increased expression of IL-6 and IL-8, both downstream products of the TLR 7/8 signaling pathway, following stimulation with R848 suggests that additional experiments to confirm the signaling pathway by which R848 stimulates foal neutrophils, and to investigate its ability to stimulate functional responses of foal neutrophils, are merited.


Asunto(s)
Caballos/inmunología , Imidazoles/farmacología , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , ARN Mensajero/biosíntesis , Receptor Toll-Like 8/genética , Factores de Edad , Animales , Animales Recién Nacidos , Regulación de la Expresión Génica/efectos de los fármacos , Caballos/genética , Inmunidad Innata/efectos de los fármacos , Inmunidad Innata/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Interleucina-8/genética , Interleucina-8/inmunología , Modelos Lineales , Masculino , ARN Mensajero/química , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/veterinaria , Transducción de Señal , Receptor Toll-Like 8/agonistas , Receptor Toll-Like 8/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA